AGI.do

Products

What will AGI do for Azamulin?

This classification denotes an antimicrobial with the molecular formula C24H38N4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 875AQ866X1, chemically known as ((5-amino-s-triazol-3-yl)thio)acetic acid, 8-ester with (3as,4r,5s,6r,8r,9ar,10r)-6-ethyloctahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-3a,9-propano-3ah-cyclopentacycloocten-1(4h)-one but more generally known as azamulin, which bears US NIH Compound Identifier 3086060. European Medicines Agency schedules Azamulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05633MIG. The term AZAMULIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 39, No. 5, 1985, List 25). AZAMULIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(CC(=O)OC1C2(C3C(C(C(O)C(C1)(CC)C)C)(CCC2C)CCC3=O)C)C1NC([NH]N1)N.

How AGI delivers it

Four ways AGI delivers for Azamulin

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Azamulin, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Azamulin, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Azamulin connects

measured by

  • Assay Puritymodel
  • Impurity Contentmodel
  • Residual Solventmodel

Go deeper

Explore Azamulin

Read the deeper take on agi.asView as markdown